Grandview

Grandview Analytics Joins Appian Partner Program to Accelerate Implementation and Integration for Financial Services Clients

Retrieved on: 
Tuesday, October 10, 2023
Software, Partnership, Organization, Gartner, Grandview, Data management, Philosophy, Asset management, 3D printing

CHICAGO, Oct. 10, 2023 /PRNewswire-PRWeb/ -- Chicago-based Grandview Analytics, a leading technology consulting and data management software company for financial institutions, announced today a partnership with Appian, a leading enterprise software company that helps organizations build apps and workflows rapidly with a low-code automation platform.

Key Points: 
  • Increasingly, financial services companies are interested in custom applications and workflow automation to manage their investment businesses more profitably and efficiently.
  • As an Appian partner, Grandview combines Appian expertise and resources with its strong implementation and integration capabilities, and a track record of building workflow automation solutions for clients.
  • "Appian is recognized as a driver of hyperautomation and self-service solutions, and we're thrilled to add it to the Grandview toolbox and leverage its transformational capabilities for our clients."
  • Grandview's focus on technology implementation, integration, and data management solutions, combined with Appian software, will help bring clients closer to this emerging reality.

Cancer Support Community’s New Short Documentary Film Named Official Selection at CINEHEALTH International Health and Wellness Film and Video Festival

Retrieved on: 
Wednesday, August 30, 2023
Survivor, GSK, Medicine, Partnership, Education, Health, CSC, Clinical trial, Health equity, Cancer, Research, Inside Out Film and Video Festival, University college, Black, Future, Grandview, Novartis, Trust, Welling Films, Karmanos Cancer Institute, Patient, Cancer Support Community, Knowledge, Bias, White, Multiple myeloma, Beyond Right and Wrong, Pharmaceutical industry, Medical imaging, Television, Pfizer

has been named an Official Selection of the inaugural CINEHEALTH International Health and Wellness Film and Video Festival (CINEHEALTH).

Key Points: 
  • has been named an Official Selection of the inaugural CINEHEALTH International Health and Wellness Film and Video Festival (CINEHEALTH).
  • The six-part short documentary film series explores historical and current injustices, and provides education about cancer clinical trials, the personal benefits of participation, effective community-based approaches, and strategies for achieving inclusive, quality cancer care, which includes access to clinical trials.
  • CINEHEALTH is the first and only international film festival focusing exclusively on health and wellness.
  • go to: https://www.cancersupportcommunity.org/healthequity#justified-medical-mi...
    For more information about Cancer Support Community’s health equity initiatives, including the Justified Medical Mistrust short documentary series and the Peer Clinical Trials Support Program, go to CSC’s Health Equity in Action page: https://www.cancersupportcommunity.org/healthequity
    For more information about CINEHEALTH: https://www.cine-health.com/

Grandview Analytics Makes Inc. 5000 List of Fastest-Growing Private Companies in America

Retrieved on: 
Tuesday, August 15, 2023
Data management, Financial services, Microsoft, Growth, Grandview, Software, Online shopping

CHICAGO, Aug. 15, 2023 /PRNewswire-PRWeb/ -- Chicago-based Grandview Analytics, a leading technology consulting and data management software company for financial institutions, today announced that it is No. 1358 on the annual Inc. 5000 list of fastest-growing companies in America.

Key Points: 
  • 1358 on the annual Inc. 5000 list of fastest-growing companies in America.
  • Facebook, Microsoft, Under Armour, and many other recognized name brands gained their first national exposure as honorees on the Inc. 5000.
  • "We are thrilled to be included on the Inc. 5000 list of America's fastest-growing private companies," stated Matt Biver, CEO of Grandview Analytics.
  • Grandview Analytics' inclusion on the prestigious list comes on the heels of other recent industry accolades.

Pendulum Therapeutics Announces Strategic Partnership and $10M Investment From Global Nutrition Science Leader, Fonterra

Retrieved on: 
Tuesday, June 27, 2023
Biotechnology, Diabetes, Pharmaceutical, Health, Cleveland Clinic, Partnership, Doctor of Philosophy, Ageing, Immunity, Global health, Multimedia, Research, Amazon, Gastroenterology, Therapy, Mental health, NSS, Grandview, Pharmaceutical industry, Pendulum, Fonterra

Pendulum Therapeutics , the biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, announced today a strategic partnership with New Zealand dairy nutrition company Fonterra .

Key Points: 
  • Pendulum Therapeutics , the biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, announced today a strategic partnership with New Zealand dairy nutrition company Fonterra .
  • The strategic partnership leverages Fonterra’s innovation, manufacturing expertise, and long-standing leadership in global markets, alongside Pendulum’s deep science-backed innovation, microbiome expertise and category leadership in the U.S. probiotic market.
  • This strategic partnership with Fonterra enables us to tap into their deep-rooted manufacturing expertise and established global presence to bring a new wave of microbiome products to market.”
    The $10 million investment from Fonterra will come from their newly formed nutrition science venture arm, provisionally named Nutrition Science Solutions (NSS).
  • Pendulum products are available online at Amazon , Pendulum Therapeutics website , Dr. Mark Hyman Store , Walmart Marketplace , Fullscript and The Cleveland Clinic online pharmacy.

The Cleaning Services Category to Witness Steady Demand Owing to an Increase in Outsourcing Services by Manufacturing, Chemical, and OEM Industries While Constructing New Factories - Grand View Research, Inc.

Retrieved on: 
Tuesday, June 20, 2023
Intelligence, ABM Industries, Cost, Maintenance, Partnership, SLA, Aluminium, Bankruptcy, Competitive landscape, Steel, Hygiene, Forecasting, ABM, Emerging technologies, Organization, O'Hare International Airport, Maid, Acquisition, Tropicana Field, Housekeeping, Growth, BER Airport – Terminal 1-2 station, Engagement, KPI-driven code analysis, Al Lang Stadium, Grandview, Retail, Construction

SAN FRANCISCO, June 20, 2023 /PRNewswire/ -- The cleaning services category is expected to register a CAGR of 6.7% from 2022 to 2030. The cleaning services category is driven by the increase in remote working conditions and rising consumer awareness about safety, hygiene, and sanitization.

Key Points: 
  • Outsourcing the activities related to gathering intelligence allows organizations to focus on their core offerings.
  • Through this partnership, ABM Industries aims to provide superior janitorial and cleaning services at the two venues, both of which span across one million square feet of stadium area.
  • Brief about Pipeline by Grand View Research:
    A smart and effective supply chain is essential for growth in any organization.
  • Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

The Cleaning Services Category to Witness Steady Demand Owing to an Increase in Outsourcing Services by Manufacturing, Chemical, and OEM Industries While Constructing New Factories - Grand View Research, Inc.

Retrieved on: 
Tuesday, June 20, 2023
Intelligence, ABM Industries, Cost, Maintenance, Partnership, SLA, Aluminium, Bankruptcy, Competitive landscape, Steel, Hygiene, Forecasting, ABM, Emerging technologies, Organization, O'Hare International Airport, Maid, Acquisition, Tropicana Field, Housekeeping, Growth, BER Airport – Terminal 1-2 station, Engagement, KPI-driven code analysis, Al Lang Stadium, Grandview, Retail, Construction

SAN FRANCISCO, June 20, 2023 /PRNewswire/ -- The cleaning services category is expected to register a CAGR of 6.7% from 2022 to 2030. The cleaning services category is driven by the increase in remote working conditions and rising consumer awareness about safety, hygiene, and sanitization.

Key Points: 
  • Outsourcing the activities related to gathering intelligence allows organizations to focus on their core offerings.
  • Through this partnership, ABM Industries aims to provide superior janitorial and cleaning services at the two venues, both of which span across one million square feet of stadium area.
  • Brief about Pipeline by Grand View Research:
    A smart and effective supply chain is essential for growth in any organization.
  • Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Enrolled at UCSF

Retrieved on: 
Monday, June 12, 2023
US Foods, Drug development, University, University of California, San Francisco, ADHD, USD, Doctor of Philosophy, Trial of the century, C, Plant, Patient, UCSF, Medical Center, Ophthalmology, Psychiatry, Phase, Grandview, Pharmaceutical industry, Neuroscience

The UCSF site, led by Professor Keith McBurnett, PhD, Psychiatry UCSF Weill Institute for Neurosciences, joins the five (5) Taiwan sites that have begun patient enrollment for the Company’s ADHD Phase II Part 2 clinical study.

Key Points: 
  • The UCSF site, led by Professor Keith McBurnett, PhD, Psychiatry UCSF Weill Institute for Neurosciences, joins the five (5) Taiwan sites that have begun patient enrollment for the Company’s ADHD Phase II Part 2 clinical study.
  • The study entitled “A Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients with Attention-Deficit Hyperactivity Disorder (ADHD), Part II” is a randomized, double-blind, placebo-controlled study involving a total of approximately one hundred (100) patients in the United States and Taiwan.
  • A total of fifty-three (53) participants have been enrolled and forty-three (43) have completed the eight-week study thus far.
  • “We are pleased to see the first subject enrolled and a few more subjects currently being screened for the ADHD Phase II Part 2 study at UCSF,” said Dr. Howard Doong, ABVC BioPharma’s Chief Executive Officer.

Cancer Support Community’s New Short Documentary Film Series Strives to Advance Health Equity

Retrieved on: 
Wednesday, May 31, 2023
Survivor, Medicine, Michigan State University College of Human Medicine, Education, Health, CSC, Clinical trial, Health equity, Cancer, Research, University college, Black, Grandview, Trust, Patient, Cancer Support Community, Academy Awards, Knowledge, United, Bias, White, Multiple myeloma, Beyond Right and Wrong, Pharmaceutical industry, Nursing, Medical device, Birth control

Hailed by Academy Award-nominated and Emmy and Peabody Award-winning documentarian Barak Goodman as “moving and persuasive,” the 6-part short documentary film series explores justified medical mistrust in the Black and African American communities and participation in cancer clinical trials.

Key Points: 
  • Hailed by Academy Award-nominated and Emmy and Peabody Award-winning documentarian Barak Goodman as “moving and persuasive,” the 6-part short documentary film series explores justified medical mistrust in the Black and African American communities and participation in cancer clinical trials.
  • The first documentary in the series, How Does a Clinical Trial Benefit ME?, is now available to stream.
  • The program pairs Black and African American cancer patients with Peer Specialists, specially trained Black or African American cancer patients or survivors who have participated in a clinical trial.
  • go to: https://www.cancersupportcommunity.org/healthequity#justified-medical-mi...
    For more information about CSC’s health equity initiatives, including the Justified Medical Mistrust short documentary series and the Peer Clinical Trials Support Program, go to their Health Equity in Action page: https://www.cancersupportcommunity.org/healthequity

Fit Soda™ Now Carried in Hy-Vee Grocery Stores in the Mid-West Region of the United States

Retrieved on: 
Wednesday, May 3, 2023
Sprouts, Taste, Sprouts Farmers Market, Mineral, CSE, Drink, FIT, Energy drink, Roche Bros., Fit, PepsiCo, USD, Vitamin, Food Lion, Growth, Coca-Cola, Grandview, Farmer, Soft drink, Bottled water, Coeus, Hy-Vee

Hy-Vee ranks in the Top 5 Most Trusted Brands and has been named one of America’s Top 3 favorite grocery stores.

Key Points: 
  • Hy-Vee ranks in the Top 5 Most Trusted Brands and has been named one of America’s Top 3 favorite grocery stores.
  • "We are thrilled to partner with Hy-Vee grocery stores to bring Fit Soda™ to even more customers," said Chris Miller, CEO of the Company.
  • To view Fit Soda™ Products on Hy-Vee’s website you can visit the following link: Fit Soda/Hy-Vee.
  • Fit Soda™ has been rapidly expanding and has been placed in other well-known regional grocery chains such as Food Lion , Roche Bros .

ABVC BioPharma Announces Completion of Phase II Part 2 Clinical Study Site Initiation Visit at UCSF

Retrieved on: 
Wednesday, April 26, 2023
US Foods, Drug development, University, SIV, University of California, San Francisco, ADHD, Attention deficit hyperactivity disorder, Doctor of Philosophy, CNS, Trial of the century, Plant, Patient, UCSF, Medical Center, Ophthalmology, Phase, Grandview, Pharmaceutical industry, Neuroscience

The UCSF site, led by Professor Keith McBurnett, PhD, at the UCSF Weill Institute for Neurosciences, will join five other Taiwan sites for ABVC BioPharma’s Phase II Part 2 clinical study in patients with ADHD.

Key Points: 
  • The UCSF site, led by Professor Keith McBurnett, PhD, at the UCSF Weill Institute for Neurosciences, will join five other Taiwan sites for ABVC BioPharma’s Phase II Part 2 clinical study in patients with ADHD.
  • The study entitled “A Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients with Attention-Deficit Hyperactivity Disorder (ADHD), Part II” is a randomized, double-blind, placebo-controlled study involving a total of approximately 100 patients in the United States and Taiwan.
  • The Phase II Part 2 clinical study is a continuation of the Phase II Part 1 clinical study of ABV-1505, which was completed successfully by achieving the specified primary endpoints at UCSF and accepted by the US Food & Drug Administration in October of 2020.
  • “We are pleased to have Professor Keith McBurnett leading the UCSF team to perform ADHD Phase II Part 2 study,” said Dr. Howard Doong, ABVC BioPharma’s Chief Executive Officer.